Wedgewood Communications joins imc group to expand its presence in the US market

Wedgewood Communications, a US-based full-service biopharma commercial communications and advertising agency, has joined imc group with the backing of pan-European investor Waterland Private Equity.

Wedgewood Communications represents a convergence of science, technology and creativity and employs 60 people in Holmdel, New Jersey. This strategic partnership builds upon a strong historical working relationship between the two companies and will encourage further successful agency collaborations across the imc group. Wedgewood joins imc group alongside existing imc group agencies: imc agency, Porterhouse Medical, Indigo Medical Compliance and Pulsar, giving the group a global headcount of 285 people.

Wedgewood Communications will significantly enhance the ability of the imc group to disrupt the global healthcare communications industry by offering clients a multidisciplinary approach across seven core divisions: Medical & Scientific Content, Publications, Digital & Creative, Insights & Consulting, Patient Engagement, Meetings & Events, and Medical Compliance & Material Review.

Established in 1989 by a core team with roots in the data-led and detail-intense field of medical publishing, Wedgewood Communications’ professionals work in purpose-built teams to deliver evidence-based solutions to clients across almost every therapeutic category, with the express aims of driving productivity, increasing market share and improving care outcomes. By capitalising on strategic agreements with software partners and a global network of alliances encompassing operators in North America, Europe and Asia, Wedgewood Communications can leverage the latest digital advances and data insights to drive superior outcomes for its clients from its headquarters in Holmdel, New Jersey, USA.

The financial terms of the transaction are not disclosed.

Tom Timko, Chief Operating Officer at Wedgewood Communications, commented: “Having known the quality of work produced by Shairose and her standout team for several years, we are thrilled to join their effort to shake up the global healthcare communications industry. We’re excited that this collaboration with imc will expand our service offerings to Wedgewood’s client teams, and that our pooled resources and expertise will be game-changing for the brands that we support.”

Shairose Ebrahim, Chief Executive Officer of imc group, commented: “Having worked with the team at Wedgewood Communications previously, I have first-hand experience of their exceptional dedication, ingenuity and ability. We are delighted to be partnering with them and we look forward to taking our combined offering to the next level in the service of our clients on both sides of the Atlantic.”

Dominic Graham, Investment Director at Waterland Private Equity, added: “Wedgewood Communications’ personalised approach and proprietary technology have secured their competitive edge and customer appeal across three decades. By working together, their offering is transformed, their expertise unmatched, and their future bright. This is an important step in imc’s broader strategy, allowing us to serve our clients with market leading capabilities in the US and on a global basis”.

Company enquiries:

• imc group: Shairose Ebrahim, shairose@imcmedcom.com
• Wedgewood Communications: Lisa Marion, lmarion@wedgecom.com

Press enquiries:

• Maitland: Alasdair Lennon, alennon@maitland.co.uk +44 (0) 7342 704 229

About imc group:

imc group is a leading, independent global healthcare communication group that enables clients’ brands to connect with healthcare professionals, payers and patients through transformative end-to-end solutions, scientific rigour, insights, and medical excellence. imc group offers its client partners a full range of omnichannel insights and medical compliance services that span the entire drug lifecycle and all therapeutic areas. With a geographic footprint in Europe, Canada, the USA and MEA, and a client list that comprises many leading pharmaceutical, biopharma and diagnostic companies, the group provides a boutique approach to delivery and customises strategies that address with precision the needs of each client.

More information: www.imcmedcom.com

About Wedgewood Communications: Wedgewood Communications is a full-service commercial communications and advertising agency with a focus on biopharma organisations and their specialty products. Its independent approach and thinking provide innovative strategies that consistently lead to success in the marketplace. Wedgewood Communications’ principles inherently rely on collaboration for customised strategic solutions, scientific excellence and impactful creative execution from concept to completion. Through its established medical expertise and industry-leading digital capabilities, the agency offers personalised solutions to address its clients’ most difficult communication challenges with an independent yet collaborative spirit.

More information: www.wedgecom.com

About Waterland Private Equity Waterland is an independent private equity firm founded in the Netherlands in 1999. Over the last 20 years, Waterland has made investments in over 600 companies across over 100 markets. Waterland manages €8 billion in funds and has teams based in the UK, Ireland, France, the Netherlands, Belgium, Germany, Poland, Switzerland and Denmark, and operates across Europe.

More information: www.waterlandpe.co.uk